Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences > Food and Drugs Law
KordaMentha
The pharmacy industry is moving from community-based dispensaries to discount pharmaceutical and healthcare retailers.
Holding Redlich
This newsletter has links and summaries to recent media releases, reports and cases relating to the healthcare industry.
DeHeng Law Offices
此等问题的正解且待新药法实施细则和《药品注册管理办法》修订来澄清。
DeHeng Law Offices
2019年8月26日,《药品管理法》经修订后通过,其中原法第三十九条第二款的"医疗单位临床急需或者个人自用进口的少量药品,按照国家有关规定
King & Capital Law Firm
近日,由京都律师事务所合伙人汤建彬律师承办的河北最大贩毒案由保定市中级
King & Capital Law Firm
于某某贩卖毒品死刑复核案,历时3年多,最高人民法院在充分
King & Capital Law Firm
近日,北京市京都律师事务所合伙人汤建彬律师承
Hogan Lovells
T he past year is set to be a milestone year for China's pharmaceutical regulatory reform as the newly formed National Medical Products Administration (NMPA) continues to aggressively cut back on red
Ropes & Gray LLP
On April 20, 2019, the Chinese government submitted a second draft of the Drug Administration Law of the People's Republic of China to the Standing Committee of the NPC for deliberation.
Cyril Amarchand Mangaldas
Gujarat has been the flag bearer of India's pharmaceutical industry since the establishment of the country's second oldest drug company
AMLEGALS
The focus of the regulation is to make the Companies accountable for their claims on food products and cater to the interest of customers.
Nishith Desai Associates
Regulation of medical devices has speedily evolved in the preceding two years. Before the introduction of the Medical Device Rules, 2017 ("MDR 2017"), the regulation of medical devices
S.S. Rana & Co. Advocates
Since time immemorial, India has been one of the most preferred sources of procuring products for sale in the market worldwide.
S.S. Rana & Co. Advocates
But the treating doctor called back the Complainant only at 10.30 p.m. as she was out of station.
S.S. Rana & Co. Advocates
Cannabis, also known as ‘marijuana' among other names is a psychoactive drug from the Cannabis plant used for medical or recreational purposes.
Nishith Desai Associates
The first half of 2019 has witnessed a lot of activity in the pharma space, so much so that the e-pharmacy saga – a pressing development towards the close of 2018 - has taken a temporary backseat this year.
Obhan & Associates
The development of new drug molecules has never been easy and is full of challenges, some of which include the following:
AZB & Partners
On June 20, 2019, CCI penalised Jalgaon District Medicine Dealers Association (‘JDMDA') as well as its office bearers, i.e., the President and Secretary of JDMDA
Singh & Associates
Under Trade-Related Aspects of Intellectual Property Rights (TRIPS)' there was no access to medicines for underdeveloped countries for treating serious health issues.
Singh & Associates
It takes at least ten years for a new medicine to complete its journey from initial discovery to marketplace in treating patients.
Latest Video
Most Popular Recent Articles
Cyril Amarchand Mangaldas
Gujarat has been the flag bearer of India's pharmaceutical industry since the establishment of the country's second oldest drug company
Singh & Associates
The Rules introduced the conditions for providing post-trial access of drugs to patients who require it for the first time.
Khurana and Khurana
Intellectual property is an intangible form of property while a ‘Patent' is a subset of intellectual property.
Khurana and Khurana
Trademarks play a vital role in creating a brand name and goodwill of any business. Not only does it helps in creating a brand value but also, aids in revenue generation.
Singh & Associates
It takes at least ten years for a new medicine to complete its journey from initial discovery to marketplace in treating patients.
Saint Island International Patent & Law Offices
At the beginning of January 2018, a patent linkage system was promulgated and introduced into the Pharmaceutical Affairs Act.
Cyril Amarchand Mangaldas
Issues around payment of compensation in cases of clinical trial related injury, disability and death have long remained open. Despite a directive
Nishith Desai Associates
The first half of 2019 has witnessed a lot of activity in the pharma space, so much so that the e-pharmacy saga – a pressing development towards the close of 2018 - has taken a temporary backseat this year.
Obhan & Associates
The development of new drug molecules has never been easy and is full of challenges, some of which include the following:
Nishith Desai Associates
Regulation of medical devices has speedily evolved in the preceding two years. Before the introduction of the Medical Device Rules, 2017 ("MDR 2017"), the regulation of medical devices
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter